BioCryst Advancing Potential Treatment for Rare and Severely Debilitating Fibrodysplasia Ossifica… Post author:Sam Post published:January 4, 2018 Post category:BioPharma FOP is a very rare disease that affects approximately 1 in 2 million people worldwide. Source: BioSpace You Might Also Like Meet the BioPharma Vet Frantically Raising Cash for His Biotech Startup August 17, 2017 Celgene Bangs Out Deal Worth $775 Million for Kendall Square Startup Delinia January 25, 2017 The Biotech That Has Almost Doubled in 2017 With the Potential to Boom Even More November 21, 2017
